Oxaliplatin/5FU/LV in the adjuvant treatment of stage II and stage III colon cancer:: Efficacy results with a median follow-up of 4 years.

被引：0
|
作者：
de Gramont, A
Boni, C
Navarro, M
Tabernero, J
Hickish, T
Topham, C
Bonetti, A
Clingan, P
Marceau-Suissa, J
Lorenzato, C
André, T
机构：
[1] Hop St Antoine, F-75571 Paris, France
[2] Arcispedale S Maria Nuova, Reggio Emilia, Italy
[3] Hosp Duran i Reynals, Lhospitalet De Llobregat, Spain
[4] Hosp Gen Valle Hebron, Barcelona, Spain
[5] Dorset Canc Ctr, Bournemouth, Dorset, England
[6] Royal Surrey Cty Hosp, Guildford, Surrey, England
[7] Mater Salutis Hosp, Legnago, Italy
[8] So Med Day Care Ctr, Wollongong, NSW, Australia
[9] Sanofi Synthelabo Rech, Chilly Mazarin, France
[10] Hop Tenon, F-75970 Paris, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：246S / 246S
页数：1
相关论文
共 50 条
  • [1] Oxaliplatin/5FU/LV in adjuvant colon cancer: Updated efficacy results of the MOSAIC trial, including survival, with a median follow-up of six years
    de Gramont, A.
    Boni, C.
    Navarro, M.
    Tabernero, J.
    Hickish, T.
    Topham, C.
    Bonetti, A.
    Clingan, P.
    Lorenzato, C.
    Andre, T.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [2] Oxaliplatin/5FU/LV in stage II and III Colon Cancer: Updated results (as of January 04) for efficacy and neurotoxicity of the MOSAIC trial
    de Gramont, Aimery
    Boni, Corrado
    Navarro, Matilde
    Tabernero, Josep
    Hickish, Tamas
    Topham, Clare
    Bonetti, Andrea
    Clingan, Philip
    Marceau-Suissa, Jeanne
    Andre, Thierry
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 73 - 73
  • [3] Stage II patients in the "MOSAIC" trial evaluating Oxaliplatin/5FU/LV as adjuvant treatment of colon cancer: a subpopulation analysis
    Hickish, Tamas
    Boni, Corrado
    Navarro, Matilde
    Tabernero, Josep
    Bonetti, Andrea
    Clingan, Philip
    Figer, Arie
    Andre, Thierry
    de Gramont, Aimery
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 76 - 76
  • [4] Cost-effectiveness analysis of oxaliplatin/5-FU/LV in adjuvant treatment of stage III colon cancer in the US
    Aballea, S
    Chancellor, J
    Raikou, M
    Drummond, M
    Weinstein, M
    Jourdan, S
    Carita, P
    Bridgewater, J
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 254S - 254S
  • [5] Cost-effectiveness analysis of oxaliplatin/5-FU/LV in adjuvant treatment of stage III colon cancer in the UK
    Aballea, S.
    Chancellor, J. V. M.
    Raikou, M.
    Drummond, M. F.
    Jourdan, S.
    Carita, P.
    Bridgewater, J.
    Boler, A.
    [J]. EJC SUPPLEMENTS, 2005, 3 (02): : 178 - 178
  • [6] Cost-effectiveness analysis of oxaliplatin/5-FU/LV in adjuvant treatment of stage III colon cancer in Germany
    Aballea, S.
    Frick, M.
    Diel, R.
    Rosenfeld, S.
    Huppertz, E.
    Sievert, M.
    Jourdan, S.
    Drummond, M.
    Weinstein, M. C.
    Reichardt, P.
    [J]. EJC SUPPLEMENTS, 2005, 3 (02): : 182 - 183
  • [7] Cost-Effectiveness of Adjuvant FOLFOX and 5FU/LV Chemotherapy for Patients with Stage II Colon Cancer
    Ayvaci, Mehmet U. S.
    Shi, Jinghua
    Alagoz, Oguzhan
    Lubner, Sam J.
    [J]. MEDICAL DECISION MAKING, 2013, 33 (04) : 521 - 532
  • [8] Economic evaluation of adjuvant chemotherapy in Stage III (SIII) colon cancer: Capecitabine versus 5FU/LV.
    Virik, K.
    Skedgel, C.
    Younis, T.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 312S - 312S
  • [9] Cost-effectiveness analysis of oxaliplatin/5-fu/lv in adjuvant treatment of stage III colon cancer in the UK and Germany
    Aballea, S
    Chancellor, J
    Raikou, M
    Drummond, M
    Diel, R
    Frick, M
    Rosenfeld, S
    Boler, A
    Jourdan, S
    Paulo, C
    Bridgewater, J
    [J]. VALUE IN HEALTH, 2005, 8 (06) : A21 - A21
  • [10] Validation of the 12-gene colon cancer recurrence score (RS) in NSABP C07 as a predictor of recurrence in stage II and III colon cancer patients treated with 5FU/LV (FU) and 5FU/LV+oxaliplatin (FU plus Ox)
    O'Connell, Michael
    Lee, Mark
    Lopatin, Margarita
    Yothers, Greg
    Clark-Langone, Kim
    Millward, Carl
    Paik, Soonmyung
    Sharif, Saima
    Shak, Steven
    Wolmark, Norman
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
12345